Alphatec Holdings, Inc. (ATEC) shares surged 9.5% to $17.46 during the last trading session, rebounding from an 18.5% loss over the previous four weeks. The increase was fueled by optimism regarding preliminary financial results, forecasting total revenue of $890 million in 2026—up 17% from 2025. Additionally, Alphatec secured exclusive U.S. distribution rights for Theradaptive’s OsteoAdapt, a next-gen rhBMP-2 solution.
In terms of earnings, ATEC is projected to report $0.04 per share in its upcoming financials, marking a 117.4% year-over-year increase, with expected revenues at $212.6 million, reflecting a 20.3% rise from the prior quarter. Current consensus earnings per share estimates have remained stable over the last 30 days.
Meanwhile, Integer Holdings Corporation (ITGR) finished 0.7% higher at $85.28 and has seen a 14.3% return over the last month. Its upcoming EPS estimate stands at $1.7, an 18.9% increase from last year.
